Fisher Asset Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-55,432
| Closed | -$101K | – | 1049 |
|
|
2024
Q4 | $101K | Buy |
55,432
+550
| +1% | +$1.01K | ﹤0.01% | 961 |
|
|
2024
Q3 | $93.3K | Sell |
54,882
-1,190
| -2% | -$2.02K | ﹤0.01% | 912 |
|
|
2024
Q2 | $76.8K | Buy |
56,072
+1,090
| +2% | +$1.49K | ﹤0.01% | 967 |
|
|
2024
Q1 | $206K | Buy |
54,982
+28
| +0.1% | +$105 | ﹤0.01% | 937 |
|
|
2023
Q4 | $539K | Buy |
54,954
+72
| +0.1% | +$706 | ﹤0.01% | 766 |
|
|
2023
Q3 | $458K | Hold |
54,882
| – | – | ﹤0.01% | 858 |
|
|
2023
Q2 | $730K | Hold |
54,882
| – | – | ﹤0.01% | 827 |
|
|
2023
Q1 | $636K | Hold |
54,882
| – | – | ﹤0.01% | 824 |
|
|
2022
Q4 | $449K | Hold |
54,882
| – | – | ﹤0.01% | 849 |
|
|
2022
Q3 | $319K | Hold |
54,882
| – | – | ﹤0.01% | 816 |
|
|
2022
Q2 | $243K | Hold |
54,882
| – | – | ﹤0.01% | 840 |
|
|
2022
Q1 | $499K | Sell |
54,882
-10
| -0% | -$91 | ﹤0.01% | 730 |
|
|
2021
Q4 | $1.12M | Buy |
54,892
+6,043
| +12% | +$124K | ﹤0.01% | 623 |
|
|
2021
Q3 | $1.25M | Buy |
48,849
+13,437
| +38% | +$343K | ﹤0.01% | 582 |
|
|
2021
Q2 | $1.24M | Sell |
35,412
-23,244
| -40% | -$813K | ﹤0.01% | 584 |
|
|
2021
Q1 | $1.95M | Buy |
58,656
+1,282
| +2% | +$42.7K | ﹤0.01% | 540 |
|
|
2020
Q4 | $1.49M | Sell |
57,374
-21,177
| -27% | -$549K | ﹤0.01% | 551 |
|
|
2020
Q3 | $775K | Buy |
+78,551
| New | +$775K | ﹤0.01% | 594 |
|